title: Beta-adrenoceptor antagonists affect amyloid nanostructure; amyloid hydrogels as drug delivery vehicles.
abstract: Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.
authors.affiliation: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
authors.forename: Jenifer
authors.initials: J
authors.lastname: Mains
authors.forename: Dimitrios A
authors.initials: DA
authors.lastname: Lamprou
authors.forename: Lisa
authors.initials: L
authors.lastname: McIntosh
authors.forename: Iain D H
authors.initials: ID
authors.lastname: Oswald
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Urquhart
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000737:chemistry / Q000378:metabolism*; D000682:Amyloid / Q000737:chemistry / Q000378:metabolism*; D002942:Circular Dichroism; D004337:Drug Carriers / Q000737:chemistry*; D020100:Hydrogels / Q000737:chemistry*; D006860:Hydrogen Bonding; D018625:Microscopy, Atomic Force; D009113:Muramidase / Q000737:chemistry / Q000378:metabolism; D049329:Nanostructures / Q000737:chemistry*; D017433:Protein Structure, Secondary
chemical_list: D000319:Adrenergic beta-Antagonists; D000682:Amyloid; D004337:Drug Carriers; D020100:Hydrogels; D009113:Muramidase